Doctors track antibiotic in sickest liver patients
NCT ID NCT05960006
Summary
This study aimed to understand how the antibiotic ceftriaxone moves through and leaves the bodies of patients with severe, decompensated liver cirrhosis. Researchers observed 20 hospitalized patients who were already receiving this antibiotic and a procedure to drain abdominal fluid. They collected leftover blood and fluid samples to measure drug levels, with the goal of improving future dosing guidelines for similar patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam university medical centers location AMC
Amsterdam, 1105AZ, Netherlands
Conditions
Explore the condition pages connected to this study.